Shares of Allurion Technologies, Inc. (ALUR) tumbled nearly 11% on Wednesday morning after the company’s fourth-quarter (Q4) ...

(Operator Instructions) Good morning, and thank you for joining us. Earlier today, Allurion Technologies Inc., Issued a press release announcing financial results for the quarter ended December 31 ...

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric ...

Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $7 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $15.75 per share a year ago. These ...

9 analyst firms have reported ratings in the last year. The last downgrade for Allurion Technologies Inc happened on November 14, 2024 when Chardan Capital changed their price target from N/A to N ...

Good morning, and thank you all for joining us. Earlier today, Allurion Technologies Inc. issued a press release announcing financial results for the quarter ended December 31st, 2024 and provided ...

NATICK, Mass., April 03, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that its Special Meeting of ...

Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...